Thrivent Financial For Lutherans Moderna, Inc. Transaction History

Thrivent Financial For Lutherans

$49.6 Billion
Q2 2024

A detailed history of Thrivent Financial For Lutherans transactions in Moderna, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 25,711 shares of MRNA stock, worth $1.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,711

Previous 25,784 0.28%

Holding current value

$1.69 Million

Previous $2.75 Million 11.1%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $7,388 - $12,162	-73 Reduced 0.28%	25,711 $3.05 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $1.02 Million - $1.38 Million	11,992 Added 86.95%	25,784 $2.75 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $8,758 - $13,158	-126 Reduced 0.91%	13,792 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1.45 Million - $1.9 Million	-15,011 Reduced 51.89%	13,918 $1.44 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $123,477 - $167,272	-1,042 Reduced 3.48%	28,929 $3.52 Million
Q1 2023 May 17, 2023	BUY	$135.66 - $197.02 $1.68 Million - $2.43 Million	12,359 Added 70.17%	29,971 $4.59 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $174,136 - $308,968	1,471 Added 9.11%	17,612 $3.16 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $37,073 - $60,972	-314 Reduced 1.91%	16,141 $1.91 Million
Q2 2022 Aug 16, 2022	BUY	$117.13 - $176.59 $20,849 - $31,433	178 Added 1.09%	16,455 $2.35 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $1.17 Million - $2.17 Million	-9,248 Reduced 36.23%	16,277 $2.8 Million
Q4 2021 Feb 16, 2022	SELL	$225.82 - $368.51 $4.4 Million - $7.18 Million	-19,483 Reduced 43.29%	25,525 $6.43 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $2.06 Million - $4.49 Million	-9,270 Reduced 17.08%	45,008 $17.3 Million
Q2 2021 Sep 24, 2021	BUY	$129.91 - $234.98 $352,705 - $637,970	2,715 Added 5.27%	54,278 $12.8 Million
Q2 2021 Aug 19, 2021	SELL	$129.91 - $234.98 $155,762 - $281,741	-1,199 Reduced 2.27%	51,563 $12.1 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $5.17 Million - $8.81 Million	47,347 Added 874.37%	52,762 $6.91 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $355,982 - $919,791	5,415 New	5,415 $566,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Moderna, Inc. Transaction History